In recent years, we have witnessed a remarkable healthcare revolution. Thanks to advances in genetic analysis, molecular biology and cell science, we now know more about the human condition than ever before. This wealth of information opens the door for the next revolution in medicine – treatments that are truly tailored for each patient....
Tucked among the acres of farmland in Amish country is a clinic that treats its patients in ways that may be a harbinger of medicine's high tech future....
The Food and Drug Administration on Monday approved a drug for a wide range of cancers based on a shared mutation, rather than the tumors' locations — an advance for the sometimes controversial field of “precision medicine.”...
Dorothy Farrar Edwards, PhD and Beth Burnside, MD lead UW-Madison's participation in the All of Us Research Program, an historic, nationwide effort led by the National Institutes of Health, to help speed up health research. ...
Eric Dishman is a living, breathing advertisement for the ambitious experiment he’s in charge of, the National Institutes of Health’s “All of Us” drive to collect and analyze the genomes of a million Americans....
A Q&A with Dr. Dara Richardson-Heron, Chief Engagement Officer with All of Us, in which she discusses the program's mission and goals, including its focus on health equity....
Precision medicine in oncology – the tailoring of treatments to individual patients rather than a one-size-fits-all approach – could perhaps be expressed in philosophical terms as meaning that no patient is an average, and every patient is unique....